Abstract:Objective:: Cancer poses a great threat to human health, and effective drugs to treat it are always needed. Several compounds containing a 2-aminopyrazine framework have been identified as antitumor agents with SHP2 inhibition activities. This current work aimed to search for more potent novel compounds possessing a 2-aminopyrazine moiety with antitumor activities. Methods:: A series of 12 novel 2-aminopyrazine derivatives was synthesized, and their structures were confirmed by spectroscopic techniques. The inhibitory activities of all the synthesized compounds against MDA-MB-231 and H1975 cancer cell lines were evaluated by an MTT assay. The most potent compound 3e was analyzed by flow cytometry. Subsequently, computational studies were performed to investigate the possible antitumor mechanisms of compound 3e. Results:: The results indicated that compound 3e exhibited potent antitumor activities with IC50 values of 11.84±0.83μM against H1975 cells and 5.66±2.39μM against MDA-MB-231 cells, which were more potent than the SHP2 inhibitor GS493 (IC50 = 19.08±1.01 μM against H1975 cells and IC50 = 25.02±1.47 μM against MDA-MB-231 cells). Further analysis by flow cytometry demonstrated that compound 3e induced cell apoptosis in H1975 cells. The results of the molecular docking and MD simulations, including RMSD, RMSF, PCA, DCCM and binding energy and decomposition analyses, revealed that compound 3e probably selectively inhibited SHP2. Conclusion:: A new compound having a 2-aminopyrazine substructure with potent inhibitory activities against the H1975 and MDA-MB-231 cancer cells was obtained, meriting further investigation as an antitumor drug.

Advances in the Research of Pyrazole Derivatives with Antitumor Activity

Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents

Pyrazole Derivatives As Antitumor, Anti-Inflammatory and Antibacterial Agents

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules

Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review

Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds

Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d] pyrimidine derivatives

Design, synthesis and anticancer activities evaluation of novel pyrazole modified catalpol derivatives

Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d]pyrimidine derivatives.

Structural Activity Relationship-based Medicinal perceptions of Pyrazoline derivatives as Anti-Cancer Agents: A Review

FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application

Design, Synthesis, Antitumor Activity Evaluation, and Molecular Dynamics Simulation of Some 2-Aminopyrazine Derivatives

Recent progress on triterpenoid derivatives and their anticancer potential

A Review on the Anticancer Activity of Carbazole-based Tricyclic Compounds

Advances in Antitumor Drugs

Current scenario of pyrazole hybrids with anti-breast cancer therapeutic applications

Pharmacological activity and mechanism of pyrazines

Research Progress on Quercetin's Biological Activity and Structural Modification Based on Its Antitumor Effects

Research status of anti-tumor targted drugs

Synthesis and Anti-tumor Activity of Novel 2-Amino-1,3,4-thiadiazole Derivativers